Barinthus Biotherapeutics to deregister ADS

Barinthus Biotherapeutics filed to terminate SEC registration of its American Depositary Shares, moving to deregister and delist the securities. Holder count for the American Depositary Shares stood at 1 as of the filing date. The termination notice was signed on Sept. 21, 2026.